CD81 and hepatocellular carcinoma: To investigate whether CD81 promotes hepatoma motility, we assessed the ability of HepG2 and Huh-7.5 cells to invade collagen I extracellular matrix and to migrate in a scratch wound assay, features that are considered to define hepatoma metastatic potential in vivo.